Mari Mino-Kenudson Selected Research

1-phenyl-3,3-dimethyltriazene (PDT)

11/2023	Immunofluorescence profiling of collagen subtypes is a predictor of treatment outcomes in pancreatic cancer.
1/2022	Remediating Desmoplasia with EGFR-Targeted Photoactivable Multi-Inhibitor Liposomes Doubles Overall Survival in Pancreatic Cancer.
1/2008	Buried Barrett's epithelium following photodynamic therapy shows reduced crypt proliferation and absence of DNA content abnormalities.
3/2007	Buried dysplasia and early adenocarcinoma arising in barrett esophagus after porfimer-photodynamic therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mari Mino-Kenudson Research Topics

Disease

140	Neoplasms (Cancer) 05/2024 - 03/2007
41	Lung Neoplasms (Lung Cancer) 05/2024 - 03/2010
41	Adenocarcinoma 03/2024 - 12/2006
35	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024 - 10/2010
22	Carcinoma (Carcinomatosis) 04/2024 - 01/2006
21	Adenocarcinoma of Lung 04/2023 - 08/2009
15	Pancreatic Neoplasms (Pancreatic Cancer) 11/2023 - 08/2005
11	Inflammation (Inflammations) 01/2023 - 05/2006
10	Neoplasm Metastasis (Metastasis) 01/2022 - 05/2006
8	Neoplasms, Cystic, Mucinous, and Serous 01/2021 - 07/2007
7	Cysts 05/2021 - 12/2013
6	Necrosis 01/2021 - 02/2007
6	Metaplasia 01/2021 - 01/2006
6	Breast Neoplasms (Breast Cancer) 01/2020 - 08/2011
5	Pancreatic Cyst 05/2021 - 06/2014
5	Barrett Esophagus (Barrett's Esophagus) 01/2021 - 03/2007
5	Fibrosis (Cirrhosis) 01/2017 - 07/2011
4	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2023 - 01/2019
4	Residual Neoplasm 11/2023 - 03/2007
4	Chronic Pancreatitis 01/2023 - 12/2006
4	Adenoma (Adenomas) 01/2021 - 01/2008
4	Carcinogenesis 01/2021 - 11/2007
4	Pancreatitis 01/2021 - 10/2009
4	Melanoma (Melanoma, Malignant) 11/2019 - 08/2008
4	Colonic Neoplasms (Colon Cancer) 01/2017 - 08/2005
4	Circulating Neoplastic Cells 11/2016 - 10/2013
4	Colorectal Neoplasms (Colorectal Cancer) 02/2016 - 11/2007
3	Mucinous Adenocarcinoma (Mucinous Carcinoma) 01/2021 - 12/2012
3	Pancreatic Intraductal Neoplasms 06/2020 - 12/2016
3	Gastritis 11/2019 - 01/2007
3	Polyps 09/2019 - 01/2008
3	Autoimmune Pancreatitis 04/2011 - 12/2006
2	Tertiary Lymphoid Structures 03/2024 - 04/2023
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 12/2023 - 12/2017
2	Respiratory Insufficiency (Respiratory Failure) 12/2023 - 01/2021
2	Virus Diseases (Viral Diseases) 01/2022 - 11/2020
2	Mesothelioma 01/2022 - 01/2020
2	COVID-19 12/2021 - 01/2021
2	Hemorrhage 02/2021 - 05/2006
2	Lymphatic Metastasis 01/2021 - 04/2009
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 01/2019

Drug/Important Bio-Agent (IBA)

31	Biomarkers (Surrogate Marker)IBA 04/2024 - 11/2005
18	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2009
13	Immune Checkpoint InhibitorsIBA 04/2024 - 04/2016
13	Anaplastic Lymphoma KinaseIBA 01/2022 - 10/2010
11	CrizotinibIBA 01/2019 - 10/2010
10	Tyrosine Kinase InhibitorsIBA 05/2024 - 03/2011
10	xylometazoline (stas)IBA 05/2024 - 01/2016
10	MucinsIBA 12/2018 - 05/2006
9	ErbB Receptors (EGF Receptor)IBA 01/2023 - 03/2011
9	B7-H1 AntigenIBA 09/2022 - 01/2017
8	Colloids (Colloid)IBA 04/2024 - 12/2011
8	RNA (Ribonucleic Acid)IBA 04/2023 - 01/2009
7	Monoclonal AntibodiesIBA 05/2021 - 08/2008
7	Phosphotransferases (Kinase)IBA 11/2019 - 08/2009
6	CollagenIBA 11/2023 - 12/2013
6	LigandsIBA 11/2019 - 04/2016
6	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 08/2005
5	Irinotecan (Camptosar)FDA LinkGeneric 01/2022 - 05/2006
5	Carcinoembryonic AntigenIBA 12/2021 - 06/2014
5	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2014 - 01/2013
4	1-phenyl-3,3-dimethyltriazene (PDT)IBA 11/2023 - 03/2007
4	AntigensIBA 01/2022 - 05/2012
4	Formaldehyde (Formol)FDA Link 10/2020 - 01/2012
4	AntibodiesIBA 01/2020 - 01/2007
4	Phosphatidylinositols (Phosphatidylinositol)IBA 02/2015 - 08/2013
3	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 12/2023 - 01/2021
3	Transcription Factors (Transcription Factor)IBA 12/2023 - 11/2016
3	lorlatinibIBA 11/2023 - 01/2018
3	Interleukin-33IBA 01/2023 - 12/2019
3	folfirinoxIBA 01/2023 - 07/2020
3	Arginine (L-Arginine)FDA Link 01/2023 - 06/2013
3	FibrinIBA 12/2021 - 11/2010
3	Mechanistic Target of Rapamycin Complex 1IBA 01/2021 - 07/2013
3	Codon (Codons)IBA 01/2021 - 06/2013
3	ChromatinIBA 12/2020 - 01/2014
3	ParaffinIBA 10/2020 - 08/2005
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2020 - 05/2011
3	Amylases FDA Link 03/2017 - 03/2007
3	ChitinasesIBA 11/2015 - 09/2011
3	AlpelisibIBA 02/2015 - 07/2013
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2011 - 01/2008
2	ChemokinesIBA 03/2024 - 04/2023
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2023 - 03/2015
2	OrnithineIBA 01/2023 - 01/2017
2	Paclitaxel (Taxol)FDA LinkGeneric 12/2021 - 03/2007
2	InterleukinsIBA 01/2021 - 12/2019
2	amsonic acid (DAS)IBA 01/2021 - 09/2012
2	CateninsIBA 01/2021 - 09/2011

Therapy/Procedure

57	Therapeutics 04/2024 - 11/2005
16	Immunotherapy 04/2024 - 02/2016
11	Neoadjuvant Therapy 01/2024 - 01/2014
11	Drug Therapy (Chemotherapy) 01/2023 - 11/2005
6	Photochemotherapy (Photodynamic Therapy) 11/2023 - 03/2007
5	Pancreatectomy 01/2021 - 02/2011
3	Radiotherapy 06/2023 - 10/2014
3	Aftercare (After-Treatment) 01/2021 - 07/2013
3	Conservative Treatment 06/2014 - 07/2007
3	Injections 03/2011 - 03/2007
2	Chemoradiotherapy 05/2024 - 03/2018